Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
RECONJOINT: A Decision Tool for Patient-Centered Breast Reconstruction Care
Ronnie Shammas MD
2024
Memorial Sloan Kettering Cancer Center (MSK)
National Endowment for Plastic Surgery Grant
Breast (Cosmetic / Reconstructive), Economics/Quality/Outcomes
Project Summary: Approximately 40% of breast reconstruction patients experience dissatisfaction due to inaccurate expectations of post-surgical well-being, and aesthetic and physical outcomes of surgery that do not reflect personal treatment preferences. The decisions surrounding breast reconstruction involve trade-offs between multiple simultaneous concerns (i.e. complications, recovery time) to arrive at a treatment that is reflective of personal preferences and values. Thus, it is essential to understand which aspects of breast reconstruction are most important to each patient when making patient-centered treatment decisions. Adaptive Choice-Based Conjoint analysis is a form of preference elicitation that shows extraordinary promise in health care to determine how patients value different aspects of treatment. By utilizing conjoint analysis, the relative importance of various treatment attributes can be determined and communicated to the provider to better align treatment preferences with the ultimate outcome. In the context of breast reconstruction, conjoint analysis can determine which attributes of reconstructive surgery are most important to a patient when communicating the shared treatment decision and can be used as part of a decision tool to facilitate shared decision-making (SDM) and individualize breast reconstruction care. Our preliminary work has developed a decision tool, based on conjoint analysis for patients considering breast reconstruction (RECONJOINT). The goal of this proposal is to optimize the workflow for RECONJOINT to support SDM and then assess the effectiveness and implementation potential of this decision tool in clinical practice. Our specific aims are the following Aim 1: Optimize the Use of RECONJOINT in clinical care through identification of site-specific facilitators and barriers, Aim 2.1: Assess the effectiveness of the RECONJOINT decision tool, and Aim 2.2: Evaluate potential for implementation of the RECONJOINT decision tool. Our central hypothesis is that eliciting treatment preferences with RECONJOINT will support a SDM process and enable surgeons to identify treatment strategies most in line with patient values. Our long-term goal is to develop a clinically relevant decision tool that will improve decisional satisfaction, involvement in SDM, and patient-centered care.
Impact Statement: This work is impactful, because RECONJOINT has the promise to improve SDM through: 1) the identification of breast reconstruction attributes which are most meaningful to an individual patient, and 2) the encouragement of bidirectional communication between patients and surgeons. In turn, this will enhance SDM with thousands of patients facing decisions for breast reconstruction. These findings will help ensure the scalability and implementation of this decision tool and will be crucial in supporting a larger, multi-institutional RCT to evaluate the RECONJOINT decision tool in clinical practice.
